Special Report
Establishing a Core Outcome Set for Peritoneal Dialysis: Report of the SONG-PD (Standardized Outcomes in Nephrology–Peritoneal Dialysis) Consensus Workshop

https://doi.org/10.1053/j.ajkd.2019.09.017Get rights and content

Outcomes reported in randomized controlled trials in peritoneal dialysis (PD) are diverse, are measured inconsistently, and may not be important to patients, families, and clinicians. The Standardized Outcomes in Nephrology–Peritoneal Dialysis (SONG-PD) initiative aims to establish a core outcome set for trials in PD based on the shared priorities of all stakeholders. We convened an international SONG-PD stakeholder consensus workshop in May 2018 in Vancouver, Canada. Nineteen patients/caregivers and 51 health professionals attended. Participants discussed core outcome domains and implementation in trials in PD. Four themes relating to the formation of core outcome domains were identified: life participation as a main goal of PD, impact of fatigue, empowerment for preparation and planning, and separation of contributing factors from core factors. Considerations for implementation were identified: standardizing patient-reported outcomes, requiring a validated and feasible measure, simplicity of binary outcomes, responsiveness to interventions, and using positive terminology. All stakeholders supported inclusion of PD-related infection, cardiovascular disease, mortality, technique survival, and life participation as the core outcome domains for PD.

Introduction

Peritoneal dialysis (PD) is a cost-effective dialysis modality that enables patients to have a greater degree of autonomy and freedom compared with hemodialysis.1 However, major challenges to the uptake and longevity of PD remain, including technique failure, infection, catheter problems, and treatment burden.2,3 Despite the increasing number of trials aiming to improve outcomes for patients receiving PD, the evidence for interventions to improve patient-important outcomes remains limited by the predominant use of surrogate end points that have not been validated and highly heterogeneous outcomes, many of which may not be relevant to patients.4,5

Mortality and technique failure are reported in only 38% and 29% of trials, respectively.6 Outcomes related to quality of life, including flexibility with time, the ability to travel or work, and fatigue, are of high priority for patients receiving PD and their families.7 However, quality of life is reported in <15% of trials in PD, and fatigue, in <5% of trials.6 The absence of patient-important outcomes in trials8,9 in nephrology more generally and other medical specialties is well recognized. Initiatives such as the Core Outcome Measures in Effectiveness Trials (COMET), Outcome Measures in Rheumatology (OMERACT), and Standardized Outcomes in Nephrology (SONG) have been launched to bring together patients, caregivers, and health professionals to identify critically important outcomes, to ensure that trials consistently report relevant and meaningful outcomes to better inform shared decision making.10, 11, 12, 13

The SONG-PD initiative commenced in 2016 and aims to develop a core outcome set to be reported in all trials in PD.7,14,15 A core outcome set is defined as an agreed minimum set of standardized outcomes to be measured and reported in all trials in a defined clinical population.16 Having identified a consensus-based prioritized list of outcome domains through an international online Delphi survey,15 a consensus workshop was convened for patients, caregivers, and health professionals to review and discuss the potential core outcome domains. The aim of this workshop report is to describe stakeholders’ perspectives and considerations on the core outcome set for PD and to establish the core outcome set to be used in all trials in PD.

Section snippets

Overview and Context

The SONG-PD consensus workshop was convened at the 17th Congress of the International Society for Peritoneal Dialysis (May 7, 2018) in Vancouver, Canada, to elicit stakeholder perspectives on the potential core outcome set for PD. The potential core outcomes were based on data from an international 3-round Delphi survey that was completed online by patients, caregivers, and health professionals with experience or expertise in PD. The Delphi survey included outcome domains reported in trials in

Overview

The discussion was summarized into themes relating to the identification of the core outcome domains and considerations for implementation, which are described in the following section. Selected quotations supporting each theme are provided in Box 1. Box 2 provides a summary of recommendations based on the workshop discussions. Figure 2 reveals the SONG-PD core outcome domains.

Reflecting Need for Flexibility and Freedom

The reasons why patients chose PD as their preferred treatment modality included the desire to have the flexibility and

Postworkshop Consultation

All participants received a draft workshop report and were asked to provide feedback within a 2-week time frame. The SONG-PD core outcome set (Fig 2) was also sent to all participants for review and comment and was uploaded on the SONG website for feedback and comment (https://songinitiative.org/projects/song-pd/). Feedback was integrated into the final report, and the findings from the workshop were used to establish the SONG-PD core outcome domains.

Discussion

Patients who participated in the workshop valued the flexibility of PD therapy and wanted to preserve and prolong technique survival and avoid transfer to hemodialysis, which were critical for consideration in identifying the core outcome domains. Fatigue was recognized as a potentially debilitating symptom that could impair life participation. Clinical outcomes (ie, membrane function and catheter complications) that did not necessarily lead to irreversible PD technique failure were not

Article Information

SONG-PD Consensus Workshop Investigators

Health Professionals: Adeera Levina; Adrian Liewb; Alfonso Cueto Manzanoc; Ali Abu Alfad; Alicia Neue; Allison Tongf; Amanda Baumgartf; Amelie Bernier-Jeanf; Amy Kellyf; Ana Figueiredog; Andrea Matush; Andrea Viecellii; Angela Juf; Angela Yee-Moon Wangj; Anjali Saxenak; Ankit Sharmaf; Annie-Claire Nadeau-Fredettel; Armando Teixeira-Pintof; Asher Mendelsonm; Ayano Kellyn; Bak Leong Goho; Benedicte Sautenetp; Braden Mannsq; Brenda Hemmelgarnq; Bruce Robinsonr; Camilla Hansonf; Catherine Cheungs;

References (24)

  • S. Svensson et al.

    Surrogate outcomes in clinical trials: a cautionary tale

    JAMA Intern Med

    (2013)
  • K.E. Manera et al.

    Scope and heterogeneity of outcomes reported in randomized trials in patients receiving peritoneal dialysis [abstract]

    J Am Soc Nephrol

    (2017)
  • Cited by (93)

    • Nutrition in Peritoneal Dialysis

      2023, Advances in Kidney Disease and Health
    View all citing articles on Scopus

    Complete author and article information (including a list of the SONG-PD Workshop Investigators) provided before references.

    View full text